The below from Pattersons Report. The whole report makes a great...

The below from Pattersons Report.

The whole report makes a great read (http://www.eastlandmedical.com.au/Uploads/Images/EMS%20Pat%20Report.pdf)

• Commercialisation timeline.
July 2009 – September 2009: Completion of capital raising and
announcement of host nation/s for Phase III clinical trials.
September 2009 – March 2010: Start trials, commence report
writing and complete initial report for interim license application.
January 2009 – March 2010: Commence W.H.O product pre
qualification process (allows for multi market entry).
March 2010 onwards: Finalise data collection and notify all
Ministries of Health within Africa of the ArTiMistTM trial notifying them of
the clinical outcomes for infants and children with complicated malaria.
Assuming the ideal outcome of Phase III approval and consequent
national license grants, Eastland® can commence production on an
initial 10 million units of ArTiMistTM.